These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
572 related items for PubMed ID: 30929872
1. [Dermatomyositis-like syndrome revealing statin-induced necrotizing autoimmune myopathy with anti-HMGCR antibodies]. Merlant M, Fite C, Kottler D, Maisonobe L, Dossier A, Deschamps L, Descamps V. Ann Dermatol Venereol; 2019 Sep; 146(8-9):550-556. PubMed ID: 30929872 [Abstract] [Full Text] [Related]
2. Clinico-serologic features of statin-induced necrotising autoimmune myopathy in a single-centre cohort. Waters MJ, Limaye V. Clin Rheumatol; 2018 Feb; 37(2):543-547. PubMed ID: 28905130 [Abstract] [Full Text] [Related]
3. [Anti-HMG-CoA reductase necrotizing myopathy: A report of 4 cases]. Marti J, Kolev I, Lorleac'h A, Besnard S, Pihan M, Marcorelles P. Rev Med Interne; 2017 Apr; 38(4):228-234. PubMed ID: 27876175 [Abstract] [Full Text] [Related]
4. An Unusual Case of Statin-Induced Myopathy: Anti-HMGCoA Necrotizing Autoimmune Myopathy. Nichols L, Pfeifer K, Mammen AL, Shahnoor N, Konersman CG. J Gen Intern Med; 2015 Dec; 30(12):1879-83. PubMed ID: 25855481 [Abstract] [Full Text] [Related]
5. Anti-HMGCR antibodies demonstrate high diagnostic value in the diagnosis of immune-mediated necrotizing myopathy following statin exposure. Shovman O, Gilburd B, Chayat C, Lazar AD, Amital H, Blank M, Bentow C, Mahler M, Shoenfeld Y. Immunol Res; 2017 Feb; 65(1):276-281. PubMed ID: 27618830 [Abstract] [Full Text] [Related]
7. Exploring necrotizing autoimmune myopathies with a novel immunoassay for anti-3-hydroxy-3-methyl-glutaryl-CoA reductase autoantibodies. Drouot L, Allenbach Y, Jouen F, Charuel JL, Martinet J, Meyer A, Hinschberger O, Bader-Meunier B, Kone-Paut I, Campana-Salort E, Eymard B, Tournadre A, Musset L, Sibilia J, Marie I, Benveniste O, Boyer O, French Myositis Network [CN]. Arthritis Res Ther; 2014 Feb 03; 16(1):R39. PubMed ID: 24484965 [Abstract] [Full Text] [Related]
8. [Immune-mediated necrotizing myopathy associated with antibodies to hydroxy-methyl-glutaryl-coenzyme A reductase]. Hinschberger O, Lohmann C, Lannes B, Martzolff L, Vo BD, Jaeger-Bizet F, Ciobanu E, Kieffer P. Rev Med Interne; 2014 Aug 03; 35(8):546-9. PubMed ID: 23910221 [Abstract] [Full Text] [Related]
9. Statin-naïve anti-HMGCR antibody-mediated necrotizing myopathy in China. Jiao Y, Cai S, Lin J, Zhu W, Xi J, Li J, Yue D, Zhang T, Qiao K, Wang Y, Zhao C, Lu J. J Clin Neurosci; 2018 Nov 03; 57():13-19. PubMed ID: 30205933 [Abstract] [Full Text] [Related]
10. Immune-mediated myopathy related to anti 3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies as an emerging cause of necrotizing myopathy induced by statins. Lahaye C, Beaufrére AM, Boyer O, Drouot L, Soubrier M, Tournadre A. Joint Bone Spine; 2014 Jan 03; 81(1):79-82. PubMed ID: 23953224 [Abstract] [Full Text] [Related]
11. Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study. Musset L, Allenbach Y, Benveniste O, Boyer O, Bossuyt X, Bentow C, Phillips J, Mammen A, Van Damme P, Westhovens R, Ghirardello A, Doria A, Choi MY, Fritzler MJ, Schmeling H, Muro Y, García-De La Torre I, Ortiz-Villalvazo MA, Bizzaro N, Infantino M, Imbastaro T, Peng Q, Wang G, Vencovský J, Klein M, Krystufkova O, Franceschini F, Fredi M, Hue S, Belmondo T, Danko K, Mahler M. Autoimmun Rev; 2016 Oct 03; 15(10):983-93. PubMed ID: 27491568 [Abstract] [Full Text] [Related]
12. Clinical Features and Treatment Outcomes of Necrotizing Autoimmune Myopathy. Kassardjian CD, Lennon VA, Alfugham NB, Mahler M, Milone M. JAMA Neurol; 2015 Sep 03; 72(9):996-1003. PubMed ID: 26192196 [Abstract] [Full Text] [Related]
14. Immune-mediated necrotizing myopathy due to statins exposure. Villa L, Lerario A, Calloni S, Peverelli L, Matinato C, DE Liso F, Ceriotti F, Tironi R, Sciacco M, Moggio M, Triulzi F, Cinnante C. Acta Myol; 2018 Dec 03; 37(4):257-262. PubMed ID: 30944904 [Abstract] [Full Text] [Related]
15. Anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase autoantibody-positive necrotizing autoimmune myopathy with dermatomyositis-like eruption. Parikh P, Tavee J, Soltanzadeh P, Mammen AL, McKeever P, Li Y. Muscle Nerve; 2018 Jun 03; 57(6):E135-E136. PubMed ID: 29346706 [No Abstract] [Full Text] [Related]
16. Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy. Werner JL, Christopher-Stine L, Ghazarian SR, Pak KS, Kus JE, Daya NR, Lloyd TE, Mammen AL. Arthritis Rheum; 2012 Dec 03; 64(12):4087-93. PubMed ID: 22933019 [Abstract] [Full Text] [Related]
18. Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects. Mammen AL, Pak K, Williams EK, Brisson D, Coresh J, Selvin E, Gaudet D. Arthritis Care Res (Hoboken); 2012 Feb 03; 64(2):269-72. PubMed ID: 21972203 [Abstract] [Full Text] [Related]
19. [Two cases of statin-induced immune-mediated necrotizing myopathy]. Safi T, Wagner H. Lakartidningen; 2021 Dec 01; 118():. PubMed ID: 34861042 [Abstract] [Full Text] [Related]
20. Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy. Mammen AL, Chung T, Christopher-Stine L, Rosen P, Rosen A, Doering KR, Casciola-Rosen LA. Arthritis Rheum; 2011 Mar 01; 63(3):713-21. PubMed ID: 21360500 [Abstract] [Full Text] [Related] Page: [Next] [New Search]